Efficacy and safety of colchicine in COVID-19: a meta-analysis of randomised controlled trials

BACKGROUND: Colchicine, an anti-inflammatory drug is prescribed nowadays for COVID-19. In this meta-analysis, we evaluated efficacy and safety of colchicine in patients with COVID-19. METHODS: We searched databases for randomised controlled studies evaluating efficacy and/or safety of colchicine as...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehta, Kedar Gautambhai, Patel, Tejas, Chavda, Paragkumar D, Patel, Parvati
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Infections
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561824/
https://www.ncbi.nlm.nih.gov/pubmed/34810227
http://dx.doi.org/10.1136/rmdopen-2021-001746

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561824/
https://www.ncbi.nlm.nih.gov/pubmed/34810227
http://dx.doi.org/10.1136/rmdopen-2021-001746

Ejemplares similares